title: Counterpoint: why biogenerics are a strawman.
authors.affiliation: Regulatory, Quality and Compliance, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA. snyder.robin@gene.com
authors.forename: Rob
authors.initials: R
authors.lastname: Garnick
mesh_terms: D001702:Biopharmaceutics; D001709:Biotechnology / Q000331:legislation & jurisprudence*; D017277:Drug Approval; D004345:Drug Industry; D016568:Drugs, Generic; D007880:Legislation, Drug; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic